

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 9.13854342 |
| 2 | epoxygenase P450 pathway (GO:0019373) | 8.29116375 |
| 3 | omega-hydroxylase P450 pathway (GO:0097267) | 8.09931432 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.62297989 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 7.62297989 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.28138303 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 7.28138303 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.86345065 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.45796949 |
| 10 | tryptophan catabolic process (GO:0006569) | 6.17648012 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 6.17648012 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 6.17648012 |
| 13 | drug metabolic process (GO:0017144) | 6.06529483 |
| 14 | kynurenine metabolic process (GO:0070189) | 6.05081930 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.96331593 |
| 16 | tryptophan metabolic process (GO:0006568) | 5.82205206 |
| 17 | oxidative demethylation (GO:0070989) | 5.81332364 |
| 18 | glyoxylate metabolic process (GO:0046487) | 5.79366691 |
| 19 | urea cycle (GO:0000050) | 5.75009210 |
| 20 | urea metabolic process (GO:0019627) | 5.75009210 |
| 21 | negative regulation of fibrinolysis (GO:0051918) | 5.71513352 |
| 22 | high-density lipoprotein particle remodeling (GO:0034375) | 5.68222899 |
| 23 | alpha-linolenic acid metabolic process (GO:0036109) | 5.62924885 |
| 24 | regulation of fibrinolysis (GO:0051917) | 5.50014231 |
| 25 | ethanol metabolic process (GO:0006067) | 5.43055670 |
| 26 | protein carboxylation (GO:0018214) | 5.42511768 |
| 27 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.42511768 |
| 28 | cysteine metabolic process (GO:0006534) | 5.36720200 |
| 29 | sulfur amino acid catabolic process (GO:0000098) | 5.36292595 |
| 30 | complement activation, alternative pathway (GO:0006957) | 5.32334466 |
| 31 | regulation of protein activation cascade (GO:2000257) | 5.31497354 |
| 32 | nitrogen cycle metabolic process (GO:0071941) | 5.28402469 |
| 33 | serine family amino acid catabolic process (GO:0009071) | 5.14657707 |
| 34 | regulation of plasminogen activation (GO:0010755) | 5.13109926 |
| 35 | phenylpropanoid metabolic process (GO:0009698) | 5.12441113 |
| 36 | bile acid metabolic process (GO:0008206) | 5.11827625 |
| 37 | regulation of cholesterol esterification (GO:0010872) | 5.00437745 |
| 38 | aromatic amino acid family metabolic process (GO:0009072) | 4.98751931 |
| 39 | reverse cholesterol transport (GO:0043691) | 4.96556865 |
| 40 | regulation of complement activation (GO:0030449) | 4.95399688 |
| 41 | negative regulation of hemostasis (GO:1900047) | 4.94653029 |
| 42 | negative regulation of blood coagulation (GO:0030195) | 4.94653029 |
| 43 | regulation of triglyceride catabolic process (GO:0010896) | 4.88644083 |
| 44 | plasma lipoprotein particle remodeling (GO:0034369) | 4.87732850 |
| 45 | protein-lipid complex remodeling (GO:0034368) | 4.87732850 |
| 46 | macromolecular complex remodeling (GO:0034367) | 4.87732850 |
| 47 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.86632537 |
| 48 | tyrosine metabolic process (GO:0006570) | 4.86153059 |
| 49 | homocysteine metabolic process (GO:0050667) | 4.80394351 |
| 50 | S-adenosylmethionine metabolic process (GO:0046500) | 4.72239399 |
| 51 | phospholipid efflux (GO:0033700) | 4.70545785 |
| 52 | alpha-amino acid catabolic process (GO:1901606) | 4.67256570 |
| 53 | amino-acid betaine metabolic process (GO:0006577) | 4.66703017 |
| 54 | negative regulation of sterol transport (GO:0032372) | 4.65975475 |
| 55 | negative regulation of cholesterol transport (GO:0032375) | 4.65975475 |
| 56 | negative regulation of protein activation cascade (GO:2000258) | 4.61496948 |
| 57 | lysine catabolic process (GO:0006554) | 4.61045211 |
| 58 | lysine metabolic process (GO:0006553) | 4.61045211 |
| 59 | regulation of humoral immune response (GO:0002920) | 4.55436097 |
| 60 | acute-phase response (GO:0006953) | 4.54071811 |
| 61 | negative regulation of coagulation (GO:0050819) | 4.49949623 |
| 62 | cellular ketone body metabolic process (GO:0046950) | 4.49188551 |
| 63 | plasma lipoprotein particle clearance (GO:0034381) | 4.47282737 |
| 64 | negative regulation of wound healing (GO:0061045) | 4.47026008 |
| 65 | glycine metabolic process (GO:0006544) | 4.43685374 |
| 66 | bile acid and bile salt transport (GO:0015721) | 4.42552880 |
| 67 | * acylglycerol homeostasis (GO:0055090) | 4.42321370 |
| 68 | * triglyceride homeostasis (GO:0070328) | 4.42321370 |
| 69 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.40323541 |
| 70 | daunorubicin metabolic process (GO:0044597) | 4.40043578 |
| 71 | polyketide metabolic process (GO:0030638) | 4.40043578 |
| 72 | doxorubicin metabolic process (GO:0044598) | 4.40043578 |
| 73 | indolalkylamine metabolic process (GO:0006586) | 4.38125857 |
| 74 | imidazole-containing compound metabolic process (GO:0052803) | 4.36264672 |
| 75 | coenzyme catabolic process (GO:0009109) | 4.34245953 |
| 76 | cellular glucuronidation (GO:0052695) | 4.34233158 |
| 77 | cholesterol efflux (GO:0033344) | 4.31686362 |
| 78 | cellular amino acid catabolic process (GO:0009063) | 4.29843863 |
| 79 | amine catabolic process (GO:0009310) | 4.28964751 |
| 80 | cellular biogenic amine catabolic process (GO:0042402) | 4.28964751 |
| 81 | glutamate metabolic process (GO:0006536) | 4.25543775 |
| 82 | positive regulation of blood coagulation (GO:0030194) | 4.23661850 |
| 83 | positive regulation of hemostasis (GO:1900048) | 4.23661850 |
| 84 | hormone catabolic process (GO:0042447) | 4.20397301 |
| 85 | serine family amino acid metabolic process (GO:0009069) | 4.19685370 |
| 86 | alkaloid metabolic process (GO:0009820) | 4.18846011 |
| 87 | benzene-containing compound metabolic process (GO:0042537) | 4.13924212 |
| 88 | ethanol oxidation (GO:0006069) | 4.11667079 |
| 89 | low-density lipoprotein particle remodeling (GO:0034374) | 4.11354021 |
| 90 | plasma lipoprotein particle assembly (GO:0034377) | 4.08257227 |
| 91 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.08030030 |
| 92 | arginine metabolic process (GO:0006525) | 4.06427382 |
| 93 | aldehyde catabolic process (GO:0046185) | 4.05430731 |
| 94 | serine family amino acid biosynthetic process (GO:0009070) | 4.05040618 |
| 95 | fibrinolysis (GO:0042730) | 4.05016736 |
| 96 | cellular modified amino acid catabolic process (GO:0042219) | 4.04235031 |
| 97 | drug catabolic process (GO:0042737) | 4.03567173 |
| 98 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.01012888 |
| 99 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.01012888 |
| 100 | intestinal cholesterol absorption (GO:0030299) | 3.99296238 |
| 101 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.93247393 |
| 102 | blood coagulation, intrinsic pathway (GO:0007597) | 3.91695661 |
| 103 | positive regulation of coagulation (GO:0050820) | 3.89776867 |
| 104 | ketone body metabolic process (GO:1902224) | 3.88897409 |
| 105 | glucuronate metabolic process (GO:0019585) | 3.85559388 |
| 106 | uronic acid metabolic process (GO:0006063) | 3.85559388 |
| 107 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.81876348 |
| 108 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.81198481 |
| 109 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.81198481 |
| 110 | cofactor catabolic process (GO:0051187) | 3.79540489 |
| 111 | organic acid catabolic process (GO:0016054) | 3.76095510 |
| 112 | carboxylic acid catabolic process (GO:0046395) | 3.76095510 |
| 113 | complement activation, classical pathway (GO:0006958) | 3.75010784 |
| 114 | heme transport (GO:0015886) | 3.73885133 |
| 115 | protein activation cascade (GO:0072376) | 3.73748475 |
| 116 | response to mercury ion (GO:0046689) | 3.73104915 |
| 117 | complement activation (GO:0006956) | 3.72893670 |
| 118 | regulation of bile acid biosynthetic process (GO:0070857) | 3.72878981 |
| 119 | short-chain fatty acid metabolic process (GO:0046459) | 3.71890680 |
| 120 | plasma lipoprotein particle organization (GO:0071827) | 3.70221785 |
| 121 | negative regulation of complement activation (GO:0045916) | 3.67306382 |
| 122 | acetyl-CoA metabolic process (GO:0006084) | 3.66931148 |
| 123 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.66460475 |
| 124 | * cholesterol homeostasis (GO:0042632) | 3.65166299 |
| 125 | protein-lipid complex assembly (GO:0065005) | 3.65121440 |
| 126 | primary alcohol catabolic process (GO:0034310) | 3.62187087 |
| 127 | cytolysis (GO:0019835) | 3.62031033 |
| 128 | xenobiotic metabolic process (GO:0006805) | 3.61302345 |
| 129 | NAD biosynthetic process (GO:0009435) | 3.59949414 |
| 130 | * sterol homeostasis (GO:0055092) | 3.59053971 |
| 131 | sodium-independent organic anion transport (GO:0043252) | 3.56514679 |
| 132 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.56422774 |
| 133 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.56422774 |
| 134 | flavonoid metabolic process (GO:0009812) | 3.55098499 |
| 135 | regulation of cholesterol homeostasis (GO:2000188) | 3.54928101 |
| 136 | opsonization (GO:0008228) | 3.53794607 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.41715461 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.18113577 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.09853561 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.53212246 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.29317493 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.15236673 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.83236808 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.05201883 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.03517800 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.08318313 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 12.0125450 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.99390069 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.95400370 |
| 14 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60720422 |
| 15 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.59484741 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.51921844 |
| 17 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.41150092 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.39197874 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.22436067 |
| 20 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.19047420 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.16745984 |
| 22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.16416196 |
| 23 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.08228477 |
| 24 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.07597791 |
| 25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.02096963 |
| 26 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99284696 |
| 27 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.94865485 |
| 28 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.92889370 |
| 29 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.92849299 |
| 30 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.92464315 |
| 31 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.90045195 |
| 32 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.89906119 |
| 33 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.88944008 |
| 34 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.85538680 |
| 35 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.85159822 |
| 36 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.84494286 |
| 37 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.84235324 |
| 38 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.84206754 |
| 39 | * PHF8_20622853_ChIP-Seq_HELA_Human | 0.83499784 |
| 40 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.82245154 |
| 41 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.81223035 |
| 42 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.80086819 |
| 43 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.79487250 |
| 44 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.78412041 |
| 45 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.77978967 |
| 46 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.77705110 |
| 47 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.77512146 |
| 48 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.77482845 |
| 49 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.76566137 |
| 50 | * NFYA_21822215_ChIP-Seq_K562_Human | 0.76409691 |
| 51 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.75900623 |
| 52 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.73048831 |
| 53 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.72727747 |
| 54 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.72693218 |
| 55 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.71942970 |
| 56 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69887106 |
| 57 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.69835772 |
| 58 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.69262377 |
| 59 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.68013365 |
| 60 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.67361042 |
| 61 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.67285006 |
| 62 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.67285006 |
| 63 | * GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.67013636 |
| 64 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.65262947 |
| 65 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.65109120 |
| 66 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.64924608 |
| 67 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.64604679 |
| 68 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.64358481 |
| 69 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.62303606 |
| 70 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.61897250 |
| 71 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.61626880 |
| 72 | * CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.61250434 |
| 73 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.61035690 |
| 74 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.60674389 |
| 75 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.60425515 |
| 76 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.60417252 |
| 77 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.60130204 |
| 78 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.59923505 |
| 79 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.58588119 |
| 80 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57923272 |
| 81 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.57883733 |
| 82 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.57748684 |
| 83 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.57627763 |
| 84 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.56930173 |
| 85 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.56200581 |
| 86 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.55837042 |
| 87 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.55823948 |
| 88 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.55796586 |
| 89 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.55645047 |
| 90 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.55396995 |
| 91 | * ETV1_20927104_ChIP-Seq_GIST48_Human | 0.55131069 |
| 92 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.54223770 |
| 93 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.53875648 |
| 94 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.53561856 |
| 95 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.53173673 |
| 96 | AR_20517297_ChIP-Seq_VCAP_Human | 0.53038552 |
| 97 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.52306715 |
| 98 | * NFYB_21822215_ChIP-Seq_K562_Human | 0.51731249 |
| 99 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.51140093 |
| 100 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.50626676 |
| 101 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.50265262 |
| 102 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.49703598 |
| 103 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.49674521 |
| 104 | CBP_21632823_ChIP-Seq_H3396_Human | 0.49528009 |
| 105 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.49157834 |
| 106 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49117285 |
| 107 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.48992225 |
| 108 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.48347405 |
| 109 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.48129203 |
| 110 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.48080108 |
| 111 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.47177199 |
| 112 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.46407370 |
| 113 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.46261724 |
| 114 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.43701744 |
| 115 | * P53_21459846_ChIP-Seq_SAOS-2_Human | 0.43285998 |
| 116 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.43129879 |
| 117 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.42708159 |
| 118 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.42659718 |
| 119 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.42202440 |
| 120 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.41328635 |
| 121 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.41261062 |
| 122 | GATA1_19941826_ChIP-Seq_K562_Human | 0.40943392 |
| 123 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.40883153 |
| 124 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.40711201 |
| 125 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.40669124 |
| 126 | GATA2_19941826_ChIP-Seq_K562_Human | 0.38924076 |
| 127 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.38508328 |
| 128 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.37996675 |
| 129 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.37840923 |
| 130 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.37828722 |
| 131 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.37401784 |
| 132 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.37019515 |
| 133 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.36408253 |
| 134 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.36308819 |
| 135 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.36166689 |
| 136 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.34873676 |
| 137 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.34400500 |
| 138 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.34333453 |
| 139 | NCOR_22424771_ChIP-Seq_293T_Human | 0.34312553 |
| 140 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.33942052 |
| 141 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.33909891 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.34998772 |
| 2 | MP0005360_urolithiasis | 7.57875953 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.47730909 |
| 4 | MP0005365_abnormal_bile_salt | 6.21345333 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.18626126 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.29410993 |
| 7 | MP0003252_abnormal_bile_duct | 3.93076872 |
| 8 | * MP0010329_abnormal_lipoprotein_level | 3.49760849 |
| 9 | MP0009840_abnormal_foam_cell | 3.29401913 |
| 10 | MP0005083_abnormal_biliary_tract | 3.05697054 |
| 11 | MP0003195_calcinosis | 2.82981264 |
| 12 | MP0005332_abnormal_amino_acid | 2.77104022 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.59116085 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.29714040 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.15084657 |
| 16 | * MP0000609_abnormal_liver_physiology | 2.14012644 |
| 17 | * MP0002118_abnormal_lipid_homeostasis | 2.07462625 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.03432514 |
| 19 | MP0003868_abnormal_feces_composition | 1.92592168 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.83558351 |
| 21 | MP0001764_abnormal_homeostasis | 1.71740042 |
| 22 | MP0009697_abnormal_copulation | 1.70439283 |
| 23 | * MP0005584_abnormal_enzyme/coenzyme_acti | 1.49898986 |
| 24 | MP0005451_abnormal_body_composition | 1.43501646 |
| 25 | MP0003011_delayed_dark_adaptation | 1.41864144 |
| 26 | MP0003186_abnormal_redox_activity | 1.28498132 |
| 27 | MP0003656_abnormal_erythrocyte_physiolo | 1.27271736 |
| 28 | MP0009643_abnormal_urine_homeostasis | 1.22903416 |
| 29 | * MP0000598_abnormal_liver_morphology | 1.15353088 |
| 30 | MP0005647_abnormal_sex_gland | 1.13121249 |
| 31 | MP0000604_amyloidosis | 1.08701459 |
| 32 | MP0003705_abnormal_hypodermis_morpholog | 1.08430593 |
| 33 | MP0009764_decreased_sensitivity_to | 1.06825806 |
| 34 | MP0009763_increased_sensitivity_to | 1.02810875 |
| 35 | MP0002254_reproductive_system_inflammat | 1.01414108 |
| 36 | MP0010368_abnormal_lymphatic_system | 0.95081684 |
| 37 | MP0005636_abnormal_mineral_homeostasis | 0.91973261 |
| 38 | MP0001915_intracranial_hemorrhage | 0.91156721 |
| 39 | MP0008469_abnormal_protein_level | 0.89306573 |
| 40 | MP0005408_hypopigmentation | 0.87748596 |
| 41 | * MP0009642_abnormal_blood_homeostasis | 0.86453248 |
| 42 | MP0005187_abnormal_penis_morphology | 0.86279720 |
| 43 | MP0006036_abnormal_mitochondrial_physio | 0.84099984 |
| 44 | MP0005376_homeostasis/metabolism_phenot | 0.81365793 |
| 45 | MP0002876_abnormal_thyroid_physiology | 0.80928876 |
| 46 | MP0009765_abnormal_xenobiotic_induced | 0.79935438 |
| 47 | MP0005084_abnormal_gallbladder_morpholo | 0.79372571 |
| 48 | MP0002078_abnormal_glucose_homeostasis | 0.78026986 |
| 49 | MP0005670_abnormal_white_adipose | 0.76856074 |
| 50 | MP0005220_abnormal_exocrine_pancreas | 0.71521558 |
| 51 | MP0002971_abnormal_brown_adipose | 0.71016863 |
| 52 | MP0002282_abnormal_trachea_morphology | 0.70340012 |
| 53 | MP0003690_abnormal_glial_cell | 0.69350485 |
| 54 | MP0004130_abnormal_muscle_cell | 0.68635647 |
| 55 | MP0005535_abnormal_body_temperature | 0.68590290 |
| 56 | MP0001661_extended_life_span | 0.67576031 |
| 57 | MP0009053_abnormal_anal_canal | 0.67018242 |
| 58 | MP0005266_abnormal_metabolism | 0.65548327 |
| 59 | MP0003879_abnormal_hair_cell | 0.63166667 |
| 60 | MP0000639_abnormal_adrenal_gland | 0.61383312 |
| 61 | * MP0005334_abnormal_fat_pad | 0.61315501 |
| 62 | MP0003329_amyloid_beta_deposits | 0.60988454 |
| 63 | MP0001756_abnormal_urination | 0.58894646 |
| 64 | MP0005023_abnormal_wound_healing | 0.57755775 |
| 65 | MP0006035_abnormal_mitochondrial_morpho | 0.57517883 |
| 66 | MP0005448_abnormal_energy_balance | 0.54881501 |
| 67 | MP0005464_abnormal_platelet_physiology | 0.53903741 |
| 68 | MP0002249_abnormal_larynx_morphology | 0.53690491 |
| 69 | MP0002822_catalepsy | 0.49423111 |
| 70 | MP0005395_other_phenotype | 0.48054455 |
| 71 | MP0008874_decreased_physiological_sensi | 0.46919939 |
| 72 | MP0002928_abnormal_bile_duct | 0.45994176 |
| 73 | MP0003638_abnormal_response/metabolism_ | 0.45987315 |
| 74 | MP0003718_maternal_effect | 0.45902583 |
| 75 | MP0008873_increased_physiological_sensi | 0.45449254 |
| 76 | MP0004782_abnormal_surfactant_physiolog | 0.45358955 |
| 77 | MP0002136_abnormal_kidney_physiology | 0.44561899 |
| 78 | MP0000566_synostosis | 0.43542483 |
| 79 | MP0002837_dystrophic_cardiac_calcinosis | 0.42528465 |
| 80 | MP0003436_decreased_susceptibility_to | 0.42131577 |
| 81 | MP0003724_increased_susceptibility_to | 0.42127703 |
| 82 | MP0003953_abnormal_hormone_level | 0.40811435 |
| 83 | MP0003075_altered_response_to | 0.40623381 |
| 84 | MP0005248_abnormal_Harderian_gland | 0.40476364 |
| 85 | MP0009785_altered_susceptibility_to | 0.39570402 |
| 86 | MP0008872_abnormal_physiological_respon | 0.38873133 |
| 87 | MP0009672_abnormal_birth_weight | 0.37224337 |
| 88 | MP0005166_decreased_susceptibility_to | 0.36807586 |
| 89 | MP0004381_abnormal_hair_follicle | 0.35691660 |
| 90 | MP0005058_abnormal_lysosome_morphology | 0.34648408 |
| 91 | MP0005666_abnormal_adipose_tissue | 0.34150143 |
| 92 | MP0009115_abnormal_fat_cell | 0.33076237 |
| 93 | MP0004883_abnormal_blood_vessel | 0.32674555 |
| 94 | MP0000249_abnormal_blood_vessel | 0.31994523 |
| 95 | MP0006082_CNS_inflammation | 0.31874155 |
| 96 | MP0000579_abnormal_nail_morphology | 0.31393408 |
| 97 | MP0001243_abnormal_dermal_layer | 0.31252024 |
| 98 | MP0001853_heart_inflammation | 0.31188722 |
| 99 | MP0000230_abnormal_systemic_arterial | 0.31116561 |
| 100 | MP0000467_abnormal_esophagus_morphology | 0.30823971 |
| 101 | MP0002796_impaired_skin_barrier | 0.30597485 |
| 102 | MP0002168_other_aberrant_phenotype | 0.30288936 |
| 103 | MP0001851_eye_inflammation | 0.30204195 |
| 104 | MP0002970_abnormal_white_adipose | 0.29333287 |
| 105 | MP0001845_abnormal_inflammatory_respons | 0.28122208 |
| 106 | MP0001881_abnormal_mammary_gland | 0.28046830 |
| 107 | MP0005197_abnormal_uvea_morphology | 0.27182640 |
| 108 | MP0003959_abnormal_lean_body | 0.26561742 |
| 109 | MP0009384_cardiac_valve_regurgitation | 0.26392082 |
| 110 | MP0003632_abnormal_nervous_system | 0.25599363 |
| 111 | MP0005164_abnormal_response_to | 0.25546642 |
| 112 | MP0002132_abnormal_respiratory_system | 0.25357553 |
| 113 | MP0002090_abnormal_vision | 0.25242541 |
| 114 | MP0002089_abnormal_postnatal_growth/wei | 0.24012294 |
| 115 | MP0004272_abnormal_basement_membrane | 0.22876117 |
| 116 | MP0002060_abnormal_skin_morphology | 0.22118788 |
| 117 | MP0003633_abnormal_nervous_system | 0.21923411 |
| 118 | MP0000920_abnormal_myelination | 0.21392952 |
| 119 | MP0002128_abnormal_blood_circulation | 0.20751706 |
| 120 | MP0001944_abnormal_pancreas_morphology | 0.20228155 |
| 121 | MP0003631_nervous_system_phenotype | 0.18320121 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.58821779 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.47161319 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.34070838 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.73287750 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.71255163 |
| 6 | Xanthomatosis (HP:0000991) | 6.31542021 |
| 7 | * Hypobetalipoproteinemia (HP:0003563) | 5.75734436 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.65392134 |
| 9 | Complement deficiency (HP:0004431) | 5.34903040 |
| 10 | Joint hemorrhage (HP:0005261) | 4.92332021 |
| 11 | Hyperammonemia (HP:0001987) | 4.66194469 |
| 12 | Epidermoid cyst (HP:0200040) | 4.51889512 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 4.50825647 |
| 14 | Hyperglycinemia (HP:0002154) | 4.46635112 |
| 15 | * Hypolipoproteinemia (HP:0010981) | 4.44393077 |
| 16 | Abnormality of methionine metabolism (HP:0010901) | 4.34793090 |
| 17 | Ketosis (HP:0001946) | 4.28808132 |
| 18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.28466673 |
| 19 | Hypoalphalipoproteinemia (HP:0003233) | 4.25300011 |
| 20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.17850085 |
| 21 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.17775415 |
| 22 | Fat malabsorption (HP:0002630) | 4.15057343 |
| 23 | * Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.10201485 |
| 24 | Hyperglycinuria (HP:0003108) | 3.95803199 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 3.95524402 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.95524402 |
| 27 | Hypoglycemic coma (HP:0001325) | 3.94976311 |
| 28 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.91011948 |
| 29 | Abnormality of complement system (HP:0005339) | 3.89371641 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.82393707 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.77983730 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.68036752 |
| 33 | Hyperbilirubinemia (HP:0002904) | 3.39281452 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.37378518 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.36141456 |
| 36 | Delayed CNS myelination (HP:0002188) | 3.14949706 |
| 37 | Abnormality of serum amino acid levels (HP:0003112) | 3.13126736 |
| 38 | Steatorrhea (HP:0002570) | 3.12993061 |
| 39 | Osteomalacia (HP:0002749) | 3.10622486 |
| 40 | Abnormality of nucleobase metabolism (HP:0010932) | 3.08161107 |
| 41 | Ketoacidosis (HP:0001993) | 3.05439343 |
| 42 | Hypochromic microcytic anemia (HP:0004840) | 3.03704917 |
| 43 | Spontaneous abortion (HP:0005268) | 3.01776545 |
| 44 | Hepatocellular carcinoma (HP:0001402) | 2.99244576 |
| 45 | Myocardial infarction (HP:0001658) | 2.91399935 |
| 46 | Skin nodule (HP:0200036) | 2.79432807 |
| 47 | Metabolic acidosis (HP:0001942) | 2.78361779 |
| 48 | Systemic lupus erythematosus (HP:0002725) | 2.70664815 |
| 49 | Abnormality of purine metabolism (HP:0004352) | 2.66735687 |
| 50 | Fair hair (HP:0002286) | 2.65853573 |
| 51 | Lethargy (HP:0001254) | 2.63955098 |
| 52 | Acanthocytosis (HP:0001927) | 2.61655760 |
| 53 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.61028744 |
| 54 | Dicarboxylic aciduria (HP:0003215) | 2.61028744 |
| 55 | Vascular calcification (HP:0004934) | 2.58685589 |
| 56 | Purpura (HP:0000979) | 2.54717674 |
| 57 | Hypoglycemic seizures (HP:0002173) | 2.54161701 |
| 58 | Glomerulonephritis (HP:0000099) | 2.51234676 |
| 59 | Cerebral edema (HP:0002181) | 2.48869209 |
| 60 | Spastic diplegia (HP:0001264) | 2.46929098 |
| 61 | Abnormal gallbladder morphology (HP:0012437) | 2.45650183 |
| 62 | Mitral stenosis (HP:0001718) | 2.41870598 |
| 63 | Neonatal hypoglycemia (HP:0001998) | 2.41008981 |
| 64 | Cholelithiasis (HP:0001081) | 2.38620000 |
| 65 | Gout (HP:0001997) | 2.38173857 |
| 66 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.36697110 |
| 67 | Hyperphosphaturia (HP:0003109) | 2.36243420 |
| 68 | Irritability (HP:0000737) | 2.35923758 |
| 69 | Reduced antithrombin III activity (HP:0001976) | 2.35676166 |
| 70 | Pulmonary embolism (HP:0002204) | 2.35418014 |
| 71 | Neonatal onset (HP:0003623) | 2.34426004 |
| 72 | Abnormal gallbladder physiology (HP:0012438) | 2.32555340 |
| 73 | Cholecystitis (HP:0001082) | 2.32555340 |
| 74 | Amyloidosis (HP:0011034) | 2.29159505 |
| 75 | Cardiovascular calcification (HP:0011915) | 2.29037819 |
| 76 | Gingival bleeding (HP:0000225) | 2.23638804 |
| 77 | Malnutrition (HP:0004395) | 2.23186949 |
| 78 | Esophageal varix (HP:0002040) | 2.21273921 |
| 79 | Menorrhagia (HP:0000132) | 2.19434099 |
| 80 | Glycosuria (HP:0003076) | 2.17670180 |
| 81 | Abnormality of urine glucose concentration (HP:0011016) | 2.17670180 |
| 82 | Pancreatitis (HP:0001733) | 2.14454092 |
| 83 | Enlarged kidneys (HP:0000105) | 2.12122327 |
| 84 | Sensorimotor neuropathy (HP:0007141) | 2.11545556 |
| 85 | Brushfield spots (HP:0001088) | 2.10461147 |
| 86 | Thrombophlebitis (HP:0004418) | 2.09373049 |
| 87 | Late onset (HP:0003584) | 2.09187437 |
| 88 | Arthropathy (HP:0003040) | 2.09061060 |
| 89 | Vomiting (HP:0002013) | 2.08739379 |
| 90 | Generalized aminoaciduria (HP:0002909) | 2.08305023 |
| 91 | Poikilocytosis (HP:0004447) | 2.06174125 |
| 92 | Joint swelling (HP:0001386) | 2.05743128 |
| 93 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.05440791 |
| 94 | Opisthotonus (HP:0002179) | 2.03586567 |
| 95 | Abnormality of the gallbladder (HP:0005264) | 1.99158283 |
| 96 | Hemorrhage of the eye (HP:0011885) | 1.97637815 |
| 97 | Elevated alkaline phosphatase (HP:0003155) | 1.93892122 |
| 98 | Abnormality of the Achilles tendon (HP:0005109) | 1.93598662 |
| 99 | Rickets (HP:0002748) | 1.93247367 |
| 100 | Bifid scrotum (HP:0000048) | 1.92737296 |
| 101 | Renal cortical cysts (HP:0000803) | 1.91562032 |
| 102 | Abnormality of iron homeostasis (HP:0011031) | 1.91451775 |
| 103 | Increased serum ferritin (HP:0003281) | 1.89447497 |
| 104 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.88732626 |
| 105 | Abnormal urine phosphate concentration (HP:0012599) | 1.87739827 |
| 106 | Hypophosphatemic rickets (HP:0004912) | 1.87326610 |
| 107 | Abnormal cartilage morphology (HP:0002763) | 1.87152337 |
| 108 | Abnormality of proline metabolism (HP:0010907) | 1.85668188 |
| 109 | Hydroxyprolinuria (HP:0003080) | 1.85668188 |
| 110 | Alkalosis (HP:0001948) | 1.85005040 |
| 111 | Generalized hypopigmentation of hair (HP:0011358) | 1.81525696 |
| 112 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.81072405 |
| 113 | Elevated hepatic transaminases (HP:0002910) | 1.80681935 |
| 114 | Status epilepticus (HP:0002133) | 1.79659819 |
| 115 | Abnormality of vitamin metabolism (HP:0100508) | 1.78502706 |
| 116 | Nephritis (HP:0000123) | 1.77684516 |
| 117 | Increased mean platelet volume (HP:0011877) | 1.76066814 |
| 118 | Hyperglycemia (HP:0003074) | 1.74480367 |
| 119 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.74153429 |
| 120 | Epistaxis (HP:0000421) | 1.72950491 |
| 121 | Cerebral palsy (HP:0100021) | 1.72836741 |
| 122 | Gangrene (HP:0100758) | 1.70490608 |
| 123 | Abnormal delivery (HP:0001787) | 1.65283721 |
| 124 | Blue irides (HP:0000635) | 1.62323811 |
| 125 | Abnormal platelet volume (HP:0011876) | 1.57202571 |
| 126 | Bile duct proliferation (HP:0001408) | 1.54934813 |
| 127 | Abnormal biliary tract physiology (HP:0012439) | 1.54934813 |
| 128 | Potter facies (HP:0002009) | 1.53282614 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.28671524 |
| 2 | SIK1 | 4.68965607 |
| 3 | FGFR4 | 4.55697469 |
| 4 | ERN1 | 4.11933620 |
| 5 | INSRR | 3.12217757 |
| 6 | TAOK3 | 3.11991903 |
| 7 | ERBB4 | 2.79626683 |
| 8 | MAP2K4 | 2.38636956 |
| 9 | PKN2 | 2.24145756 |
| 10 | MST1R | 2.14787804 |
| 11 | FLT3 | 1.98282079 |
| 12 | PIK3CG | 1.96780052 |
| 13 | NTRK3 | 1.89565295 |
| 14 | MAPK11 | 1.82188636 |
| 15 | TYK2 | 1.73628514 |
| 16 | CAMKK2 | 1.72337201 |
| 17 | LATS1 | 1.65296554 |
| 18 | DAPK2 | 1.61848161 |
| 19 | MAP3K12 | 1.60944496 |
| 20 | TRIB3 | 1.58479453 |
| 21 | MAP3K2 | 1.57271476 |
| 22 | ABL2 | 1.53595050 |
| 23 | PRPF4B | 1.47839038 |
| 24 | FRK | 1.46398882 |
| 25 | NEK9 | 1.42530828 |
| 26 | PTK6 | 1.42224023 |
| 27 | BRSK2 | 1.41840322 |
| 28 | FGFR2 | 1.40871471 |
| 29 | KDR | 1.28938973 |
| 30 | JAK2 | 1.23806054 |
| 31 | NLK | 1.18996779 |
| 32 | MAP3K7 | 1.18199414 |
| 33 | PINK1 | 1.17561777 |
| 34 | PRKAA2 | 1.13842905 |
| 35 | MAP2K3 | 1.09929534 |
| 36 | MAP3K14 | 1.07623255 |
| 37 | GRK6 | 1.05419596 |
| 38 | FER | 1.04614612 |
| 39 | WNK3 | 1.03466255 |
| 40 | TBK1 | 1.02885599 |
| 41 | JAK1 | 1.02177346 |
| 42 | ACVR1B | 1.02049973 |
| 43 | MAPK4 | 1.00499825 |
| 44 | ERBB2 | 0.99591410 |
| 45 | MYLK | 0.95694140 |
| 46 | PRKCZ | 0.94374094 |
| 47 | MAP3K10 | 0.93251423 |
| 48 | PRKG1 | 0.91518436 |
| 49 | NEK1 | 0.88049601 |
| 50 | MAPK15 | 0.85684393 |
| 51 | KSR2 | 0.85528749 |
| 52 | MAP3K3 | 0.84888092 |
| 53 | STK38L | 0.84250948 |
| 54 | CDK6 | 0.83820928 |
| 55 | MAPK12 | 0.83714155 |
| 56 | MET | 0.82730907 |
| 57 | SCYL2 | 0.81746291 |
| 58 | PRKACA | 0.81128141 |
| 59 | TNK2 | 0.80992576 |
| 60 | PRKACG | 0.77907830 |
| 61 | TIE1 | 0.77709977 |
| 62 | EPHB1 | 0.76093504 |
| 63 | MAP3K11 | 0.73294970 |
| 64 | CAMK1D | 0.72813119 |
| 65 | EPHA3 | 0.72808879 |
| 66 | CSNK1D | 0.71425114 |
| 67 | CSK | 0.71424678 |
| 68 | MAP2K6 | 0.69067076 |
| 69 | CAMK2G | 0.68851160 |
| 70 | DYRK1B | 0.68201757 |
| 71 | GSK3A | 0.67194309 |
| 72 | SGK3 | 0.66098647 |
| 73 | IRAK3 | 0.66091635 |
| 74 | PRKAA1 | 0.65779281 |
| 75 | CSNK1E | 0.65180400 |
| 76 | PRKCB | 0.63157152 |
| 77 | MAPK7 | 0.59074031 |
| 78 | TGFBR2 | 0.58552214 |
| 79 | CSF1R | 0.57747555 |
| 80 | PRKACB | 0.57591236 |
| 81 | RPS6KA3 | 0.57285205 |
| 82 | TAOK2 | 0.56214757 |
| 83 | IKBKE | 0.55051316 |
| 84 | EPHA4 | 0.54861306 |
| 85 | FGFR3 | 0.54551678 |
| 86 | SGK2 | 0.52762489 |
| 87 | PRKCQ | 0.52577815 |
| 88 | RIPK1 | 0.51890649 |
| 89 | EIF2AK1 | 0.51487144 |
| 90 | PTK2 | 0.51260856 |
| 91 | CASK | 0.50785868 |
| 92 | CSNK1G1 | 0.50389391 |
| 93 | PDPK1 | 0.49383884 |
| 94 | EIF2AK3 | 0.47985622 |
| 95 | ZAP70 | 0.47834750 |
| 96 | MAP3K5 | 0.47344946 |
| 97 | GRK1 | 0.46996898 |
| 98 | IGF1R | 0.46951286 |
| 99 | SGK1 | 0.46193812 |
| 100 | SRC | 0.44801816 |
| 101 | PDK2 | 0.44506593 |
| 102 | PRKCG | 0.44415300 |
| 103 | CDK4 | 0.42050068 |
| 104 | PDGFRA | 0.41793826 |
| 105 | RET | 0.41467198 |
| 106 | BLK | 0.41390645 |
| 107 | CSNK2A1 | 0.40303111 |
| 108 | PBK | 0.40140852 |
| 109 | MUSK | 0.40110289 |
| 110 | MAP2K1 | 0.39970097 |
| 111 | MAP3K6 | 0.39507261 |
| 112 | FGFR1 | 0.38951800 |
| 113 | CSNK2A2 | 0.38624337 |
| 114 | MAP3K13 | 0.37421679 |
| 115 | CAMKK1 | 0.36834747 |
| 116 | PKN1 | 0.36709127 |
| 117 | SGK494 | 0.36088338 |
| 118 | SGK223 | 0.36088338 |
| 119 | BCR | 0.33821121 |
| 120 | MTOR | 0.33138532 |
| 121 | CAMK4 | 0.33010315 |
| 122 | EGFR | 0.32761577 |
| 123 | PIK3CA | 0.31765757 |
| 124 | PDK1 | 0.31349905 |
| 125 | ICK | 0.29748991 |
| 126 | CSNK1G2 | 0.29659669 |
| 127 | PRKCA | 0.27132874 |
| 128 | IRAK2 | 0.26115301 |
| 129 | CSNK1G3 | 0.25162094 |
| 130 | IRAK1 | 0.24766291 |
| 131 | AKT3 | 0.24372595 |
| 132 | CAMK1G | 0.24344797 |
| 133 | MAP3K1 | 0.23103394 |
| 134 | ABL1 | 0.22174061 |
| 135 | PDK4 | 0.21443110 |
| 136 | PDK3 | 0.21443110 |
| 137 | PAK3 | 0.20436680 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.49348082 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.61290038 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.40949420 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.39337497 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.08033681 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.77244393 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.69551833 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.69459085 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.61965798 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.53822755 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47403603 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.38626489 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.27594458 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.17326628 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.14270412 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.06422514 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.98423347 |
| 18 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.96764823 |
| 19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.96101947 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.94591347 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.90354109 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.84529512 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.80744227 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.79937242 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.77864467 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.76919225 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.74744879 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.73688302 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71243468 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.65295455 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.62287654 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.57084361 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.56536380 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.50240640 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.50185819 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.47818883 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.44300929 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.36112114 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.34285719 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.33225441 |
| 41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.31702811 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29024536 |
| 43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19898633 |
| 44 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.19620665 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.19301612 |
| 46 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.18764045 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.15748483 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.12272192 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.01933421 |
| 50 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.99439481 |
| 51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.98512462 |
| 52 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.97945757 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96403397 |
| 54 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.92334939 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.92330227 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87900521 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.84878727 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.81949473 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.81430862 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.75553837 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69437388 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66237702 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.65173025 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56473441 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53820082 |
| 66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.46900471 |
| 67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45852974 |
| 68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.41695031 |
| 69 | Prion diseases_Homo sapiens_hsa05020 | 0.33519122 |
| 70 | Pertussis_Homo sapiens_hsa05133 | 0.29826888 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25315020 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25027707 |
| 73 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23365937 |
| 74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22361817 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.21504192 |
| 76 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.20544934 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20105981 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14382781 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08789593 |
| 80 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.00835667 |
| 81 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2504140 |
| 82 | Amoebiasis_Homo sapiens_hsa05146 | -0.2482696 |
| 83 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2425784 |
| 84 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2421988 |
| 85 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.2334660 |
| 86 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2308333 |
| 87 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2141808 |
| 88 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2114319 |
| 89 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2035262 |
| 90 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2029357 |
| 91 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.1951223 |
| 92 | Hepatitis C_Homo sapiens_hsa05160 | -0.1908137 |
| 93 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1890555 |
| 94 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1865215 |
| 95 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1773751 |
| 96 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1727154 |
| 97 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1661858 |
| 98 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1658496 |
| 99 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1475062 |
| 100 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1413421 |
| 101 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1309424 |
| 102 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1073892 |
| 103 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0896160 |
| 104 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0747158 |
| 105 | Mineral absorption_Homo sapiens_hsa04978 | -0.0707729 |
| 106 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0626389 |
| 107 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0423198 |
| 108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0389685 |
| 109 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0088034 |

